Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks.
Eckhardt SG, Baker SD, Eckardt JR, Burke TG, Warner DL, Kuhn JG, Rodriguez G, Fields S, Thurman A, Smith L, Rothenberg ML, White L, Wissel P, Kunka R, DePee S, Littlefield D, Burris HA, Von Hoff DD, Rowinsky EK.
Eckhardt SG, et al. Among authors: rowinsky ek.
Clin Cancer Res. 1998 Mar;4(3):595-604.
Clin Cancer Res. 1998.
PMID: 9533526
Clinical Trial.